Charting The Path To First-In-Human: Strategic Readiness For Early Clinical Success

The path to first-in-human studies represents one of the most critical — and complex — milestones in drug development, demanding strategic foresight, seamless coordination, and a clearly defined roadmap that bridges scientific innovation with operational execution.

In this webinar, experts from inSeption Group will share proven strategies for successfully navigating early clinical readiness and IND preparation, offering practical guidance on how to anticipate challenges, align cross-functional teams, and build the operational “trail map” needed to reach first patient in an efficient and compliant manner.

Viewers will gain a comprehensive, end-to-end perspective on the journey to first-in-human and understand how early decisions influence downstream success. The session also explores how scientific, regulatory, manufacturing, and operational considerations intersect during early clinical development, highlights common risks that can delay or derail studies and how to mitigate them, and provides actionable strategies for fostering cross-functional alignment across internal teams and external partners. Watch the full presentation below to learn how thoughtful planning, the right expertise, and strong partnerships can safeguard their asset and accelerate progress to the clinic.